CURAGEN CORPORATION
CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company's strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.
CURAGEN CORPORATION
Industry:
Biopharma Biotechnology Genetics Health Care Therapeutics
Founded:
1991-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Total Employee:
101+
Status:
Active
Similar Organizations
Leptos Biomedical
Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity.
Current Employees Featured
Founder
Stock Details
More informations about "Curagen Corporation"
CuraGen Corporation Company Profile - Dun & Bradstreet
CuraGen Corporation. Website. Get a D&B Hoovers Free Trial. Overview Company Description: In the war against cancer, CuraGen is looking for the ultimate weapon. The drug company's โฆSee details»
Curagen Corporation
Feb 25, 2025 Curagen Corporation is a research-based biotechnology company dedicated to discovering and developing novel therapeutics in the life sciences industry. We are committed โฆSee details»
CuraGen Company Profile | Management and Employees List
CuraGen Profile and History. CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, and small โฆSee details»
CuraGen Corp. - Drug pipelines, Patents, Clinical trials - Synapse
May 8, 2025 Explore CuraGen Corp. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 12 news, and 114 literature, Disease Domain:Neoplasms, โฆSee details»
Celldex Therapeutics, Inc. to Buy CuraGen Corporation in $94
May 29, 2009 The deal also offers CuraGen investors reduced risk via ownership of a broader portfolio, while still retaining upside potential of CR011 in the combined company.โ CuraGen โฆSee details»
CURAGEN CORPORATION Employer Identification Number EIN
CURAGEN CORPORATION 401k plan information; State of Incorporation: Delaware, DE: Organization Addresses. The following addresses have been detected as associated with Tax โฆSee details»
Curagen Corporation | SBIR.gov
Curagen Corporation. Company Information. Address. Curagen Corporation 555 Long Wharf Dr, 11Th Fl . New Haven, CT 06511 0590. United States. Information. UEI: N/A # of ... is essential โฆSee details»
CuraGen Corporation - PubMed
1 CuraGen Corporation, 555 Long Wharf Drive, New Haven, CT 06511, USA. PMID: 12164777 DOI: 10.1517/14622416.3.4.551 Abstract CuraGen Scientists have developed a deep โฆSee details»
CuraGen Corporation: Company Profile and SWOT Analysis
CuraGen Corporation: Company Profile and SWOT Analysis Published by ICD Research at researchbeam.com [Report Price $99] 18 Pages [email protected] +1-971-202-1575 | โฆSee details»
CuraGen Corp. (CuraGen Corp.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
May 7, 2025 Biotechs Alexion Pharmaceuticals, CuraGen Corporation, Genaissance Pharmaceuticals and Neurogen Corporation all call New Haven home. Silicon Valley 10x โฆSee details»
Celldex and CuraGen Stockholders Approve Acquisition of โฆ
CuraGen Corporation is a biopharmaceutical company dedicated to improving the lives of patients by developing promising pharmaceutical products that address unmet medical needs. โฆSee details»
Celldex Therapeutics acquires CuraGen and its oncology โฆ
NEEDHAM, Mass.โCelldex Therapeutics has agreed to pay $94.5 million to acquire Branford, Conn.-based CuraGen Corp., thus gaining a portfolio of 11 oncology-focused antibodies.This โฆSee details»
Curagen Corporation - Funding, Financials, Valuation & Investors
Mar 18, 1998 Curagen Corporation is registered under the ticker NASDAQ:CRGN . Their stock opened with $12.00 in its Mar 18, 1998 IPO. Stock Symbol NASDAQ:CRGN ; Money Raised โฆSee details»
CuraGen's IPO Generates $56M For Genomics Programs - BioWorld
Oct 27, 2011 CuraGen Corp., a genomics company focused on therapeutic and agricultural products, raised $45.5 million in its initial public offering (IPO) of 3 million shares. ... CuraGen, โฆSee details»
Curagen Corporation - Contacts, Employees, Board Members
Organization. Curagen Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. โฆSee details»
Curagen Corporation - Crunchbase
CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer. New. Resources. Advanced Search ... Experience the new โฆSee details»
Curagen | PDF - SlideShare
Jan 17, 2011 Architects and Planners CuraGen Corporation 84 Orange Street New Haven, Connecticut Branford, CT Svigals collaborated with process engineers to design this 28,000 โฆSee details»
Sean Cassidy โ AbbraTech
Mr. Cassidy is the Chief Financial Officer of Arvinas. He has over 20 years of experience in the life sciences industry, including serving as Chief Financial Officer of Axerion Therapeutics, a โฆSee details»
Whatโs Driving the Surge in U.S. Corporate Profits?
Apr 21, 2025 U.S. Corporate Profits for Domestic Industries and the Rest of the World as a Share of National Income. SOURCES: Bureau of Economic Analysis and authorโs โฆSee details»
Africa Energy Announces Update To Consolidation - Newswire
2 hours ago VANCOUVER, BC, May 22, 2025 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) ("Africa Energy" or the "Company") announces an update to the โฆSee details»